NCT01658800View on ClinicalTrials.gov

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49

PHASE1CompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

VAX161C vaccine

Recombinant H5 influenza vaccine, VAX161C

Trial Locations (2)

33143

Miami Research Associates, South Miami

66219

Johnson County Clinical Trials, Lenexa

All Listed Sponsors
lead

VaxInnate Corporation

INDUSTRY

NCT01658800 - Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 | Biotech Hunter | Biotech Hunter